Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) was the target of a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 1,100 shares, a drop of 21.4% from the August 31st total of 1,400 shares. Based on an average trading volume of 13,800 shares, the short-interest ratio is currently 0.1 days.
Intelligent Medicine Acquisition Stock Down 24.9 %
Intelligent Medicine Acquisition stock traded down $0.03 during trading hours on Friday, reaching $0.09. The stock had a trading volume of 758 shares, compared to its average volume of 16,451. Intelligent Medicine Acquisition has a 52 week low of $0.03 and a 52 week high of $0.60. The company's fifty day simple moving average is $0.09.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Company Profile
(Get Rating)
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.Featured Stories
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.